Showing results (131-140 of 240) with videos related to
Sort By:
Pageof 24
Cancer Chemotherapy and Pharmacology|January 1, 1985
Clinical pharmacology of high-dose cisplatinB J Corden, R L Fine, R F Ozols, et al.Cancer Treatment Reports|November 1, 1978
Potential mechanism of macrophage-mediated tumor cell cytotoxicityA M Kaplan, J M Collins, P S Morahan, et al.Cancer Research|January 1, 1986
Alteration of the secondary structure of newly synthesized DNA from murine bone marrow cells by 5-fluorouracilJ D Schuetz, J M Collins, H J Wallace, et al.New Zealand Veterinary Journal|May 13, 2015
Serological patterns, antibody half-life and shedding in urine of Leptospira spp. in naturally exposed sheepE Vallée, C Heuer, J M Collins-Emerson, et al.Clinical Pharmacology and Therapeutics|December 1, 1983
Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinolS Zimm, J M Collins, D O'Neill, et al.Cancer Research|April 1, 1984
Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinoneS Zimm, J M Collins, G A Curt, et al.Cancer Research|December 1, 1986
Incorporation of iododeoxyuridine into DNA of granulocytes in patientsK Belanger, R W Klecker, J Rowland, et al.Cancer Research|November 1, 1984
Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkeyI G Kerr, S Zimm, J M Collins, et al.Journal of Clinical Laboratory Analysis|January 1, 1990
Simultaneous measurement of neutrophil, lymphocyte, and monocyte glutathione by flow cytometryR B Scott, J M Collins, S Matin, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 19, 1997
Rifampin and rifabutin and their metabolism by human liver esterasesC A Jamis-Dow, A G Katki, J M Collins, et al.Pageof 24